Hemokromatose - fra underdiagnostisert kuriositet til folkesykdom

Tidsskrift for den Norske Laegeforening

Volumn 129, Issue 9, 2009, Pages 863-866

  Hagve, Tor Arne ^a,b   Åsberg, Arne ^c   Ulvik, Rune ^d,e   Borch Iohnsen, Berit ^f   Thorstensen, Ketil ^c  

^a Avdeling for medisinsk biokjemi Rikshospitalet ^*  (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

BLOOD; GENETIC SCREENING; GENETICS; HEMOCHROMATOSIS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IRON OVERLOAD; MUTATION; PHLEBOTOMY; REVIEW;

FERRITINS; GENETIC SCREENING; HEMOCHROMATOSIS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IRON; IRON OVERLOAD; MUTATION; PHLEBOTOMY; TRANSFERRIN;

EID: 65549145786     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.08.0084     Document Type: Article

References (32)

1. Jim RT. Unusual test for iron overload. Lancet 1979; 2: 1028.
2. Milman N, Pedersen P. Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings. Clin Genet 2003; 64: 36-47.
3. Distante S, Robson KJ, Graham-Campbell J et al. The origin and spread of the HFE-C282Y haemochromatosis mutation. Hum Genet 2004; 115: 269-79.
4. Trousseau A. Glycosurie, diabète sucré. Clinique Médicale de l'Hotel-Dieu de Paris. Paris: Baillière, 1865: 663-98.
5. von Recklinghausen FD. Über hämochromatose. Tagbl Versamml Natur Ärtze Heidelberg 1889; 62: 324-5.
6. Sheldon JH. Haemochromatosis. London: Oxford University Press, 1935.
7. Simon M, Pawlotsky Y, Bourel M et al. Hémochromatose idiopathique: maladie associée a l'antigéne tissulaire HLA 3. Nouv Presse Méd 1975; 19: 1432.
8. Feder JN, Gnirke A, Thomas W et al. A novel MHC class-I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996; 14: 399-408.
9. Distante S, Berg JP, Lande K et al. High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression. Scand J Gastroenterol 1999; 34; 529-54.
10. Åsberg A, Hveem K, Thorstensen K et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001; 36: 1108-15.
11. Pietrangelo A. Hereditary hemochromatosis. Biochim Biophys Acta 2006; 1763; 700-10.
12. Swinkels DW, Janssen MCH, Bergmans J et al. Hereditary hemochromatosis: genetic complexity and new diagnostic approaches. Clin Chem 2006; 52: 950-68.
13. Kemna E, Tjalsma H, Laarakkers C et al. Novel urine hepcidine assay by mass spectrometry. Blood 2005; 106: 3268-70.
14. Borch-Iohnsen B, Hagve T-A, Hauge A et al. Regulering av jernbalansen. Tidsskr Nor Legeforen 2009; 129: 858-62.
15. Åsberg A, Hveem K, Krüger O et al. Persons with screening-detected hemochromatosis: as healthy as the general population? Scand J Gastroenterol 2002; 31: 719-24.
16. Olsson KS, Ritter B, Hansson N et al. The HLA-A1-B8 haplotype hitchhiking with the hemochromatosis mutation: does it affect the phenotype? Eur J Haematol 2007; 79: 429-34.
17. Porto G, Cardoso C, Gordeuk V et al. Clinical and genetic heterogeneity in hereditary haemochromatosis: association between lymphocyte counts and expression of iron overload. Eur J Haematol 2001; 67: 110-8.
18. Lin L, Valore EV, Nemeth E et al. Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Am J Hum Genet 2007; 81: 799-807.
19. Adams P, Brissot P, Powell LW. EASL International Concensus Conference on Haemochromatosis. J Hepatol 2000; 33: 485-504.
20. Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease. N Engl J Med 2004; 350: 2383-97.
21. Åsberg A, Hveem K, Halvorsen T et al. Prevalence of liver fibrosis and cirrhosis in screeningdetected C282Y homozygous subjects. Scand J Gastroenterol 2007; 43: 782-3.
22. Haukeland JW, Lorgen T, Schreiner LT et al. Incidence rates and causes of cirrhosis in a Norwegian population. Scand J Gastroenterol 2007; 42: 1501-8.
23. Swinkels DW, Jorna AT, Raymakers RA et al. Synopsis of the Dutch multidisciplinary guideline for the diagnosis and treatment of hereditary haemochromatosis. Netherl J Med 2007; 65: 452-5.
24. Beaton M, Guyader D, Deugnier Y et al. Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis. Hepatology 2002; 36: 673-8.
25. Morrison ED, Brandhagen DJ, Phatak PD et al. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med 2003; 138: 627-33.
26. Willis G, Bardsley V, Fellows IW et al. Hepatocellular carcinoma and the penetrance of HFE C282Y mutations: a cross sectional study. BMC Gastroenterol 2005; 5: 17.
27. Niederau C, Fisher R, Pürscehl A et al. Long-term survival in patients with hereditary hemochromatosis. Gatroenterology 1996; 110: 1107-19.
28. Brissot P. Diagnosis and current treatments for primary iron overload. Am J Hematol 2007; 82: 1140-1.
29. Norsk selskap for hematologi. Handlingsprogram for hemokromatose 2003. www.legeforeningen.no/asset/22333/1/22333_1.doc (27.2.2009).
30. Adams PC, Barton JC. Haemochromatosis. Lancet 2007; 370: 1855-70.
31. Åsberg A. Arvelig hemokromatose - nytten av screening. Nor J Epidemiol 2006; 16: 23-8.
32. The U.S. Preventive Task Force. Screening of hemochromatosis: recommendation statement. Ann Intern Med 2006; 145: 204-8.